{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:26:53Z","timestamp":1787574413909,"version":"build-2736575974"},"reference-count":62,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Major Research Plan of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92059201"],"award-info":[{"award-number":["92059201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["92059201"],"award-info":[{"award-number":["92059201"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Accurate assessment of axillary lymph node (ALN) status after neoadjuvant therapy (NAT) remains essential for surgical planning in patients with initially node-positive breast cancer. This study evaluated the potential value of contrast-enhanced ultrasound (CEUS) in conjunction with sentinel lymph node biopsy (SLNB) for post-NAT axillary assessment and explored clinicopathologic factors associated with lymph node (LN) status. Methods: In this retrospective study, 179 patients with cytologically confirmed node-positive breast cancer underwent CEUS after NAT, followed by surgical pathological evaluation. The observed false-negative rate (FNR) of post-NAT CEUS combined with SLNB was compared with that of SLNB alone and post-NAT ultrasound (US) combined with SLNB. Univariable and multivariable generalized estimating equation (GEE) analyses were performed to identify factors associated with LN-level outcomes. Results: A total of 213 sentinel lymph nodes were analyzed. CEUS combined with SLNB had an observed FNR of 13.25% (95% CI, 7.56\u201322.19%), which was numerically lower than the FNRs of SLNB alone and US combined with SLNB. HER2 status, hormone receptor status, breast pathological response after NAT, and CEUS findings were significantly associated with nodal status in the univariable GEE model. Exploratory multivariable GEE analyses identified pre-NAT HER2 positivity as an independent protective factor for false-negative LN outcomes, whereas pre-NAT ER status and residual invasive carcinoma were independently associated with CEUS-negative\/SLNB-positive nodal status. The exploratory models showed high apparent discrimination, with AUCs of 0.941 (95% CI, 0.890\u20130.991) and 0.917 (95% CI, 0.866\u20130.968). Conclusions: In this single-center retrospective cohort, the addition of post-NAT CEUS to SLNB was associated with a lower observed FNR than SLNB alone. These findings support the potential role of CEUS as a complementary tool for post-NAT axillary assessment but require prospective studies with external validation.<\/jats:p>","DOI":"10.3390\/cancers18172744","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:47:19Z","timestamp":1787572039000},"page":"2744","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can Contrast-Enhanced Ultrasound Reduce the False-Negative Rate of Metastatic Axillary Lymph Nodes After Neoadjuvant Therapy in Breast Cancer?"],"prefix":"10.3390","volume":"18","author":[{"given":"Sijia","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1509-659X","authenticated-orcid":false,"given":"Jiaqian","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-9525","authenticated-orcid":false,"given":"Xiaoyan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6032-0442","authenticated-orcid":false,"given":"Yanling","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"ref_1","first-page":"e70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4174\/astr.2023.105.6.360","article-title":"A simplified risk scoring system for predicting high-risk groups in gene expression tests for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, and node-positive breast cancer","volume":"105","author":"Yoon","year":"2023","journal-title":"Ann. Surg. Treat. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","article-title":"Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update","volume":"52","author":"Fisher","year":"1983","journal-title":"Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/j.semnuclmed.2022.01.006","article-title":"Sentinel Lymph Node Methods in Breast Cancer","volume":"52","author":"Giammarile","year":"2022","journal-title":"Semin. Nucl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e210891","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients with Initially Clinically Node-Positive Disease: A Systematic Review and Meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/bjs\/znab137","article-title":"Management of the axilla after neoadjuvant chemotherapy in breast cancer patients","volume":"108","author":"Boland","year":"2021","journal-title":"Br. J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/bcr281","article-title":"History of sentinel node and validation of the technique","volume":"3","author":"Tanis","year":"2001","journal-title":"Breast Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10549-023-07183-9","article-title":"Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: A retrospective cohort study","volume":"204","author":"Jia","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/bjs.10986","article-title":"Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer","volume":"105","author":"Tee","year":"2018","journal-title":"Br. J. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.breast.2021.07.015","article-title":"Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3578 patients","volume":"59","author":"Cao","year":"2021","journal-title":"Breast"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104543","DOI":"10.1016\/j.breast.2025.104543","article-title":"Effect of a machine learning prediction model on the false-negative rate of sentinel lymph node biopsy for clinically node-positive breast cancer after neoadjuvant chemotherapy","volume":"83","author":"Chen","year":"2025","journal-title":"Breast"},{"key":"#cr-split#-ref_13.1","unstructured":"Expert Panel on Breast Imaging, Hayward, J.H., Linden, O.E., Lewin, A.A., Weinstein, S.P., Bachorik, A.E., Balija, T.M., Kuzmiak, C.M., Paulis, L.V., and Salkowski, L.R. (2023). ACR Appropriateness Criteria"},{"key":"#cr-split#-ref_13.2","doi-asserted-by":"crossref","unstructured":"(R) Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update. J. Am. Coll. Radiol., 20, S125-S145.","DOI":"10.1016\/j.jacr.2023.02.016"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ultrasmedbio.2017.03.016","article-title":"Pre-Operative Evaluation of Axillary Lymph Node Status in Patients with Suspected Breast Cancer Using Shear Wave Elastography","volume":"43","author":"Youk","year":"2017","journal-title":"Ultrasound Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13244-021-01034-1","article-title":"A meta-analysis of the diagnostic performance of machine learning-based MRI in the prediction of axillary lymph node metastasis in breast cancer patients","volume":"12","author":"Chen","year":"2021","journal-title":"Insights Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00404-019-05428-x","article-title":"Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: A systematic review of the current literature","volume":"301","author":"Gruber","year":"2020","journal-title":"Arch. Gynecol. Obs."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhong, J., Luo, J., Li, J., Li, M., Liu, Y., Liang, J., Pan, F., Xie, X., and Zheng, Y. (2025). The Diagnostic Value of Multimodal Contrast-Enhanced Ultrasound in Sentinel Lymph Nodes After Neoadjuvant Therapy for Breast Cancer. Diagnostics, 15.","DOI":"10.3390\/diagnostics15192432"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.21037\/qims-23-1210","article-title":"The value of the improved percutaneous and intravenous contrast-enhanced ultrasound diagnostic classification in sentinel lymph nodes of breast cancer","volume":"14","author":"Huang","year":"2024","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.21037\/qims-2024-2879","article-title":"Factors affecting preoperative sentinel lymph nodes contrast-enhanced ultrasound in breast cancer","volume":"15","author":"Dong","year":"2025","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JOP.777003","article-title":"American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"6","author":"Hammond","year":"2010","journal-title":"J. Oncol. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tashima, R., Nishimura, R., Osako, T., Nishiyama, Y., Okumura, Y., Nakano, M., Fujisue, M., Toyozumi, Y., and Arima, N. (2015). Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119565"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mighri, N., Mejri, N., Boujemaa, M., Berrazega, Y., Rachdi, H., El Benna, H., Labidi, S., Benna, F., Boubaker, S., and Boussen, H. (2022). Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0269732"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13244-023-01430-9","article-title":"Ultrasound imaging of the axilla","volume":"14","author":"Cocco","year":"2023","journal-title":"Insights Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/uog.29127","article-title":"Ultrasound assessment of lymph nodes for staging of gynecological cancer: Consensus opinion on terminology and examination technique","volume":"65","author":"Fischerova","year":"2025","journal-title":"Ultrasound Obs. Gynecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1097\/JS9.0000000000002275","article-title":"Performance of sentinel lymph node biopsy after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: Systematic review and meta-analysis","volume":"111","author":"Zahwe","year":"2025","journal-title":"Int. J. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1245\/s10434-018-6429-2","article-title":"Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?","volume":"25","author":"Moo","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.3390\/curroncol30100630","article-title":"The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review","volume":"30","author":"Ferrarazzo","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4048\/jbc.2025.0290","article-title":"Axillary Surgery in Breast Cancer: Evidence-Based De-escalation Across Upfront and Post-Neoadjuvant Settings","volume":"29","author":"Park","year":"2026","journal-title":"J. Breast Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1245\/s10434-025-19070-2","article-title":"Oncologic Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection for Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis","volume":"33","author":"Abdulla","year":"2026","journal-title":"Ann. Surg. Oncol."},{"key":"ref_31","first-page":"11782234231176159","article-title":"Marking Techniques for Targeted Axillary Dissection Among Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy","volume":"17","author":"Gante","year":"2023","journal-title":"Breast Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients with Node-Positive Breast Cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg."},{"key":"ref_33","first-page":"1863","article-title":"Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: A prospective diagnostic and prognostic study","volume":"109","author":"Wu","year":"2023","journal-title":"Int. J. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhai, D., Tang, H., Fan, Y., AiErken, N., Zhang, M., Shi, Y., Zhang, Y., Zheng, Y., Shan, Z., and Lin, Y. (2026). Contrast-Enhanced Ultrasound Combined with Methylene Blue for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Initially cN1 Breast Cancer: A Multicenter Prospective Cohort Study. Cancers, 18.","DOI":"10.3390\/cancers18152383"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: Findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.prro.2025.09.001","article-title":"Effectiveness of Regional Nodal Irradiation in Women with a Pathologic Complete Response in the Nodes After Neoadjuvant Chemotherapy with Residual Disease in the Breast","volume":"16","author":"Karp","year":"2026","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6694023","DOI":"10.1155\/ijbc\/6694023","article-title":"Factors Influencing Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Single-Center Retrospective Study Focusing on ER and HER-2 Status","volume":"2026","author":"Zhang","year":"2026","journal-title":"Int. J. Breast Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.7150\/ijms.101855","article-title":"Development and validation of a combined ultrasound-pathology model to predict axillary status after neoadjuvant systemic therapy in breast cancer","volume":"21","author":"Shi","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"26364","DOI":"10.1038\/s41598-024-78176-x","article-title":"Differences in axillary response and treatment implications in HER2 positive node positive breast cancer during neoadjuvant HER2 targeted dual therapy","volume":"14","author":"Mou","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bedir, S., Yesilova, U.A., Tokocin, M., Cakan Demirel, B., Bozkaya, Y., Oyman, A., Guliyev, M., Abbasov, H., Demirci, N.S., and Degerli, E. (2026). Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy. Medicina, 62.","DOI":"10.3390\/medicina62010200"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamaoncol.2015.6113","article-title":"Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer with Long-Term Outcomes: A Meta-Analysis","volume":"2","author":"Broglio","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e220103","DOI":"10.1148\/rg.220103","article-title":"Multimodality Imaging Review of HER2-positive Breast Cancer and Response to Neoadjuvant Chemotherapy","volume":"43","author":"Portnow","year":"2023","journal-title":"Radiographics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9767","DOI":"10.1245\/s10434-025-17906-5","article-title":"Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer","volume":"32","author":"An","year":"2025","journal-title":"Ann. Surg. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/CM9.0000000000002849","article-title":"Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study","volume":"137","author":"Ma","year":"2024","journal-title":"Chin. Med. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1245\/s10434-024-16472-6","article-title":"Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02\/18-03","volume":"32","author":"Cabioglu","year":"2025","journal-title":"Ann. Surg. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7434","DOI":"10.1038\/s41598-026-37698-2","article-title":"The utilization of CEUS and SWE for predicting pathological complete response to neoadjuvant chemotherapy for invasive breast cancer","volume":"16","author":"Wang","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"110331","DOI":"10.1016\/j.ejso.2025.110331","article-title":"Potential for omitting sentinel lymph node biopsy in patients with human epidermal growth factor receptor 2-positive or triple negative breast cancer with non-breast pCR after neoadjuvant chemotherapy","volume":"51","author":"Shin","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Berkesoglu, M., Arslan, G., Tuncel, F., Ozcan, C., Koc, Z.P., Ozcan, P.P., Guler, E., Benli, S., Balci, Y., and Eser, K. (2025). Axillary Pathological Complete Response After Neoadjuvant Therapy in cN1-2 Breast Cancer: An Internally Validated PET\/CT-Integrated Nomogram. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32120667"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"103330","DOI":"10.1016\/j.radi.2026.103330","article-title":"Sensitivity and specificity of ultrasonic assessment of axillary lymph node for breast cancer: A diagnostic meta-analysis","volume":"32","author":"Saeed","year":"2026","journal-title":"Radiography"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cipolla, C., Gebbia, V., D\u2019Agati, E., Greco, M., Mesi, C., Scandurra, G., and Valerio, M.R. (2024). Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy. Cancers, 16.","DOI":"10.3390\/cancers16193354"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"213476","DOI":"10.1016\/j.bioadv.2023.213476","article-title":"Hydroelectric actuator for 3-dimensional analysis of electrophoretic and dielectrophoretic behavior of cancer cells; suitable in diagnosis and invasion studies","volume":"151","author":"Moharamipour","year":"2023","journal-title":"Biomater. Adv."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhuang, Y., Zhang, F., Xu, Y., He, L., Huang, W., Hong, C., and Cui, Y. (2023). Evaluating the expression of heat shock protein 27 and topoisomerase II alpha in a retrospective cohort of patients diagnosed with locally advanced breast cancer and treated with neoadjuvant anthracycline-based chemotherapies. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1067179"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103726","DOI":"10.1016\/j.breast.2024.103726","article-title":"Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive\/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signature","volume":"75","author":"Jacobs","year":"2024","journal-title":"Breast"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/mc.23837","article-title":"ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing with TRIM28 and Stabilizing LSD1 to Upregulate the AKT-GSK3beta-Snail Pathway","volume":"64","author":"Ma","year":"2025","journal-title":"Mol. Carcinog."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14740\/wjon1993","article-title":"VEGFA Gene Expression in Breast Cancer Is Associated with Worse Prognosis, but Better Response to Chemotherapy and Immunotherapy","volume":"16","author":"Sharma","year":"2025","journal-title":"World J. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zhang, X., Wang, J., Liu, Z., Wen, J., Kang, M., Fang, C., and Ren, L. (2025). BTG2-deficient mast cells remodel the tumor and tumor-draining lymph node microenvironment leading to chemotherapy resistance in breast cancer. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1562700"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1007\/s00330-024-10786-5","article-title":"Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: A multicenter study","volume":"34","author":"Fu","year":"2024","journal-title":"Eur. Radiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/JS9.0000000000002105","article-title":"Elastography-based AI model can predict axillary status after neoadjuvant chemotherapy in breast cancer with nodal involvement: A prospective, multicenter, diagnostic study","volume":"111","author":"Huang","year":"2025","journal-title":"Int. J. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/JS9.0000000000003326","article-title":"Prediction of neoadjuvant therapy response in breast cancer based on interpretable artificial intelligence","volume":"112","author":"Zhou","year":"2026","journal-title":"Int. J. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1097\/JS9.0000000000000621","article-title":"Multifactor artificial intelligence model assists axillary lymph node surgery in breast cancer after neoadjuvant chemotherapy: Multicenter retrospective cohort study","volume":"109","author":"Zhu","year":"2023","journal-title":"Int. J. Surg."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2744\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:59:17Z","timestamp":1787572757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":62,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172744"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172744","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}